447 related articles for article (PubMed ID: 29439861)
1. Enhancement of glycosylation by stable co-expression of two sialylation-related enzymes on Chinese hamster ovary cells.
Thi Sam N; Misaki R; Ohashi T; Fujiyama K
J Biosci Bioeng; 2018 Jul; 126(1):102-110. PubMed ID: 29439861
[TBL] [Abstract][Full Text] [Related]
2. Enhanced sialylation of recombinant human erythropoietin in Chinese hamster ovary cells by combinatorial engineering of selected genes.
Son YD; Jeong YT; Park SY; Kim JH
Glycobiology; 2011 Aug; 21(8):1019-28. PubMed ID: 21436238
[TBL] [Abstract][Full Text] [Related]
3. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells.
Wong NS; Yap MG; Wang DI
Biotechnol Bioeng; 2006 Apr; 93(5):1005-16. PubMed ID: 16432895
[TBL] [Abstract][Full Text] [Related]
4. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
[TBL] [Abstract][Full Text] [Related]
5. A novel sugar analog enhances sialic acid production and biotherapeutic sialylation in CHO cells.
Yin B; Wang Q; Chung CY; Bhattacharya R; Ren X; Tang J; Yarema KJ; Betenbaugh MJ
Biotechnol Bioeng; 2017 Aug; 114(8):1899-1902. PubMed ID: 28295160
[TBL] [Abstract][Full Text] [Related]
6. N-glycan sialylation in a silkworm-baculovirus expression system.
Suganuma M; Nomura T; Higa Y; Kataoka Y; Funaguma S; Okazaki H; Suzuki T; Fujiyama K; Sezutsu H; Tatematsu KI; Tamura T
J Biosci Bioeng; 2018 Jul; 126(1):9-14. PubMed ID: 29433940
[TBL] [Abstract][Full Text] [Related]
7. Lec3 Chinese hamster ovary mutants lack UDP-N-acetylglucosamine 2-epimerase activity because of mutations in the epimerase domain of the Gne gene.
Hong Y; Stanley P
J Biol Chem; 2003 Dec; 278(52):53045-54. PubMed ID: 14561743
[TBL] [Abstract][Full Text] [Related]
8. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells.
Baker KN; Rendall MH; Hills AE; Hoare M; Freedman RB; James DC
Biotechnol Bioeng; 2001 May; 73(3):188-202. PubMed ID: 11257601
[TBL] [Abstract][Full Text] [Related]
9. Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression.
Jeong YT; Choi O; Lim HR; Son YD; Kim HJ; Kim JH
J Microbiol Biotechnol; 2008 Dec; 18(12):1945-52. PubMed ID: 19131698
[TBL] [Abstract][Full Text] [Related]
10. Enhanced sialylation of recombinant erythropoietin in genetically engineered Chinese-hamster ovary cells.
Jeong YT; Choi O; Son YD; Park SY; Kim JH
Biotechnol Appl Biochem; 2009 Apr; 52(Pt 4):283-91. PubMed ID: 18590515
[TBL] [Abstract][Full Text] [Related]
11. Tumour suppressor p16(INK4a) - anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model.
Amano M; Eriksson H; Manning JC; Detjen KM; André S; Nishimura S; Lehtiö J; Gabius HJ
FEBS J; 2012 Nov; 279(21):4062-80. PubMed ID: 22943525
[TBL] [Abstract][Full Text] [Related]
12. The expression of sialyltransferases is regulated by the bioavailability and biosynthesis of sialic acids.
Bork K; Weidemann W; Berneck B; Kuchta M; Bennmann D; Thate A; Huber O; Gnanapragassam VS; Horstkorte R
Gene Expr Patterns; 2017 Jan; 23-24():52-58. PubMed ID: 28351515
[TBL] [Abstract][Full Text] [Related]
13. Engineering sialic acid synthetic ability into insect cells: identifying metabolic bottlenecks and devising strategies to overcome them.
Viswanathan K; Lawrence S; Hinderlich S; Yarema KJ; Lee YC; Betenbaugh MJ
Biochemistry; 2003 Dec; 42(51):15215-25. PubMed ID: 14690432
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the coordinated role of ST3GAL3, ST3GAL4 and ST3GAL6 on the α2,3 sialylation linkage of mammalian glycoproteins.
Chung CY; Yin B; Wang Q; Chuang KY; Chu JH; Betenbaugh MJ
Biochem Biophys Res Commun; 2015 Jul; 463(3):211-5. PubMed ID: 25998389
[TBL] [Abstract][Full Text] [Related]
15. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
[TBL] [Abstract][Full Text] [Related]
16. Integrated Genome and Protein Editing Swaps α-2,6 Sialylation for α-2,3 Sialic Acid on Recombinant Antibodies from CHO.
Chung CY; Wang Q; Yang S; Yin B; Zhang H; Betenbaugh M
Biotechnol J; 2017 Feb; 12(2):. PubMed ID: 27943633
[TBL] [Abstract][Full Text] [Related]
17. Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins.
Weikert S; Papac D; Briggs J; Cowfer D; Tom S; Gawlitzek M; Lofgren J; Mehta S; Chisholm V; Modi N; Eppler S; Carroll K; Chamow S; Peers D; Berman P; Krummen L
Nat Biotechnol; 1999 Nov; 17(11):1116-21. PubMed ID: 10545921
[TBL] [Abstract][Full Text] [Related]
18. Improvement of interferon-gamma sialylation in Chinese hamster ovary cell culture by feeding of N-acetylmannosamine.
Gu X; Wang DI
Biotechnol Bioeng; 1998 Jun; 58(6):642-8. PubMed ID: 10099302
[TBL] [Abstract][Full Text] [Related]
19. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
[TBL] [Abstract][Full Text] [Related]
20. Glycoengineering of CHO Cells to Improve Product Quality.
Wang Q; Yin B; Chung CY; Betenbaugh MJ
Methods Mol Biol; 2017; 1603():25-44. PubMed ID: 28493121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
